# A-DREAM (NCT05241860)

> Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05241860
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Alliance for Clinical Trials in Oncology
- Conditions: Castration-Sensitive Prostate Carcinoma; Stage IV Prostate Cancer AJCC v8
- Interventions: Pharmacotherapy Discontinuation; Follow-Up; Questionnaire Administration; Quality-of-Life Assessment
- Enrollment: 79
- Primary outcome: Treatment-free With Eugonadal Testosterone (>= 150 ng/dl)

## Commentary we found

- X threads: 28
- YouTube: 17
- Podcasts: 8
- X videos: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=a-dream-nct05241860

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05241860", "email": "<work email>"}; the inbox owner confirms by the emailed link.